These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26368660)

  • 1. Preparation and evaluation of a timolol maleate drug-resin ophthalmic suspension as a sustained-release formulation in vitro and in vivo.
    Qin F; Zeng L; Zhu Y; Cao J; Wang X; Liu W
    Drug Dev Ind Pharm; 2016; 42(4):535-45. PubMed ID: 26368660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
    Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
    AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
    Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
    Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery.
    Adelli GR; Balguri SP; Bhagav P; Raman V; Majumdar S
    Drug Deliv; 2017 Nov; 24(1):370-379. PubMed ID: 28165833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
    Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
    Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
    Fulgêncio Gde O; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Júnior Ada S
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye model.
    Moosa RM; Choonara YE; du Toit LC; Tomar LK; Tyagi C; Kumar P; Carmichael TR; Pillay V
    Int J Pharm; 2014 May; 466(1-2):296-306. PubMed ID: 24607446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication.
    Hathout RM; Gad HA; Abdel-Hafez SM; Nasser N; Khalil N; Ateyya T; Amr A; Yasser N; Nasr S; Metwally AA
    Int J Pharm; 2019 Feb; 556():192-199. PubMed ID: 30553005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrically atomised formulations of timolol maleate for direct and on-demand ocular lens coatings.
    Mehta P; Al-Kinani AA; Haj-Ahmad R; Arshad MS; Chang MW; Alany RG; Ahmad Z
    Eur J Pharm Biopharm; 2017 Oct; 119():170-184. PubMed ID: 28625688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro.
    Wu CJ; Huang QW; Qi HY; Guo P; Hou SX
    Pharmazie; 2006 Sep; 61(9):783-8. PubMed ID: 17020156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
    Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
    J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.
    Hegde RR; Bhattacharya SS; Verma A; Ghosh A
    Curr Eye Res; 2014 Feb; 39(2):155-63. PubMed ID: 24073659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma.
    Ilka R; Mohseni M; Kianirad M; Naseripour M; Ashtari K; Mehravi B
    Int J Biol Macromol; 2018 Apr; 109():955-962. PubMed ID: 29154878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes.
    Fukuda M; Sasaki H
    J Ocul Pharmacol Ther; 2015 Feb; 31(1):57-60. PubMed ID: 25303115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
    Singh J; Chhabra G; Pathak K
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery.
    Saroha A; Pandey P; Kaushik D
    Pharm Nanotechnol; 2017; 5(4):310-316. PubMed ID: 28847270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration.
    Ashton P; Podder SK; Lee VH
    Pharm Res; 1991 Sep; 8(9):1166-74. PubMed ID: 1788163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
    Patel N; Nakrani H; Raval M; Sheth N
    Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.